5 ESSENTIAL ELEMENTS FOR TRASTUZUMAB MOA

Just about the most below-investigated “driving forces” associated with trastuzumab resistance is PTEN. Nagata et al. (2004) claimed the lack of PTEN was observed in 36% of HER2-optimistic Key breast tumor specimens from clients with phase IV illness. Furthermore, In addition they showed that patients with PTEN-deficient tumors had remarkably l